5‐Hydroxytryptamine Medications for the Treatment of Obesity

E-ISSN： 1365-2826|27|6|389-398

ISSN： 0953-8194

Source： JOURNAL OF NEUROENDOCRINOLOGY (ELECTRONIC), Vol.27, Iss.6, 2015-06, pp. : 389-398

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options

By Isidro Maria Luisa Cordido Fernando

Pharmaceuticals, Vol. 3, Iss. 1, 2010-01 ,pp. : 125-145

MDPI

Access to resources Recommend Favorite

Combinations of Drugs in the Treatment of Obesity

By Halpern Bruno Oliveira Eduardo S. L. Faria André M. Halpern Alfredo de Melo Maria Edna Cercato Cintia Mancini Marcio C.

Pharmaceuticals, Vol. 3, Iss. 8, 2010-07 ,pp. : 2398-2415

MDPI

Access to resources Recommend Favorite

Association of annexin A5 polymorphisms with obesity

Biomedical Reports, Vol. 1, Iss. 4, 2013-01 ,pp. : 654-658

Spandidos Publications

Access to resources Recommend Favorite

Spinal neuronal activation during locomotor‐like activity enabled by epidural stimulation and 5‐hydroxytryptamine agonists in spinal rats

JOURNAL OF NEUROSCIENCE RESEARCH, Vol. 93, Iss. 8, 2015-08 ,pp. : 1229-1239

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Previous Potassium Stimulation Enhances the Increases of Striatal Extracellular Dopamine and 5‐Hydroxytryptamine During Global Ischaemia Under Simulated Penumbral Conditions

JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol. 61, Iss. 6, 1993-12 ,pp. : 2233-2238

John Wiley & Sons Inc

Access to resources Recommend Favorite